YU70895A - Postupak za pripremanje 1-(2'-deoksi-2',2'-difluoro-d-ribofuranosil)-4-(aminopirimidin-2-on)hidrohlorida - Google Patents

Postupak za pripremanje 1-(2'-deoksi-2',2'-difluoro-d-ribofuranosil)-4-(aminopirimidin-2-on)hidrohlorida

Info

Publication number
YU70895A
YU70895A YU70895A YU70895A YU70895A YU 70895 A YU70895 A YU 70895A YU 70895 A YU70895 A YU 70895A YU 70895 A YU70895 A YU 70895A YU 70895 A YU70895 A YU 70895A
Authority
YU
Yugoslavia
Prior art keywords
aminopyrimidin
deoxy
difluoro
hydrochloride
ribofuranosyl
Prior art date
Application number
YU70895A
Other languages
English (en)
Other versions
YU49314B (sh
Inventor
Richard Alan Berglund
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23397211&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=YU70895(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of YU70895A publication Critical patent/YU70895A/sh
Publication of YU49314B publication Critical patent/YU49314B/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Ovaj pronalazak obezbedjuje postupak za pripremanje gemcitabin hidrohlorida, koji obuhvata: a) deblokiranje beta-1-(2'-deoksi-2',2'-difluoro-3',5'-di-O-benzoil-D-ribofuranosii)-4-aminopirimidin-2-ona sa katalitičkom količinom alkilamina u prisustvu metanola ili etanola u sredini koja je u osnovi bez vode; b) tretiranje rezultujućeg rastvora hlorovodoničnom kiselinom i antirastvaračem; i c) rekuperovanje rezultujućeg gemcitabin hidrohlorida u čvrstom stanju.
YU70895A 1994-12-13 1995-11-13 Postupak za pripremanje 1-(2'-deoksi-2',2'-difluoro-d-ribofuranosil)-4-aminopirimidin-2-on)hidrohlorida YU49314B (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/355,372 US5637688A (en) 1994-12-13 1994-12-13 Process for preparing 1-(2'-deoxy-2'-difluoro-d-ribofuranosyl)-4-aminopyrimidin-2-one hydrochloride

Publications (2)

Publication Number Publication Date
YU70895A true YU70895A (sh) 1998-09-18
YU49314B YU49314B (sh) 2005-06-10

Family

ID=23397211

Family Applications (1)

Application Number Title Priority Date Filing Date
YU70895A YU49314B (sh) 1994-12-13 1995-11-13 Postupak za pripremanje 1-(2'-deoksi-2',2'-difluoro-d-ribofuranosil)-4-aminopirimidin-2-on)hidrohlorida

Country Status (31)

Country Link
US (2) US5637688A (sh)
EP (1) EP0719788B1 (sh)
JP (1) JPH10510806A (sh)
KR (1) KR100424991B1 (sh)
CN (1) CN1047177C (sh)
AR (1) AR001041A1 (sh)
AT (1) ATE179986T1 (sh)
AU (1) AU689674B2 (sh)
BG (1) BG62738B1 (sh)
BR (1) BR9509979A (sh)
CO (1) CO4520286A1 (sh)
CZ (1) CZ290941B6 (sh)
DE (1) DE69509624T2 (sh)
DK (1) DK0719788T3 (sh)
ES (1) ES2130542T3 (sh)
GR (1) GR3030265T3 (sh)
HU (1) HU219021B (sh)
IL (1) IL115852A (sh)
MY (1) MY112488A (sh)
NO (1) NO306783B1 (sh)
NZ (1) NZ296476A (sh)
PE (1) PE49296A1 (sh)
PL (1) PL181732B1 (sh)
RO (1) RO117327B1 (sh)
RU (1) RU2154648C2 (sh)
SI (1) SI0719788T1 (sh)
TW (1) TW379226B (sh)
UA (1) UA48152C2 (sh)
WO (1) WO1996018637A1 (sh)
YU (1) YU49314B (sh)
ZA (1) ZA959320B (sh)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5637688A (en) * 1994-12-13 1997-06-10 Eli Lilly And Company Process for preparing 1-(2'-deoxy-2'-difluoro-d-ribofuranosyl)-4-aminopyrimidin-2-one hydrochloride
EP0870506A1 (en) * 1997-04-11 1998-10-14 Eli Lilly And Company Compositions comprising a cryptophycin compound in combination with a synchronizing or activating agent for treating cancer
JP4502503B2 (ja) * 1997-12-22 2010-07-14 シェーリング コーポレイション 増殖性の疾患を処置するためのベンゾシクロヘプタピリジン化合物および抗腫瘍剤の組合せ
US6376470B1 (en) 1999-09-23 2002-04-23 Enzon, Inc. Polymer conjugates of ara-C and ara-C derivatives
WO2002028387A1 (en) * 2000-10-03 2002-04-11 Oncopharmaceutical, Inc. Inhibitors of angiogenesis and tumor growth for local and systemic administration
WO2005014010A1 (en) * 2003-07-24 2005-02-17 Eli Lilly And Company Pharmaceutical composition comprising gemcitabine and cyclodextrines
US7214791B2 (en) * 2004-07-01 2007-05-08 Shenzhen Hande Technology Co., Ltd. Method for preparation of 2′-deoxy-2′, 2′-difluoro-β-cytidine or pharmaceutically acceptable salts thereof by using 1,6-anhydro-β-d-glucose as raw material
EP1812457A1 (en) * 2004-07-30 2007-08-01 Pharmaessentia Corp. STEREOSELECTIVE SYNTHESIS OF ß-NUCLEOSIDES
WO2006070985A1 (en) * 2004-12-30 2006-07-06 Hanmi Pharm. Co., Ltd. METHOD FOR THE PREPARATION OF 2#-DEOXY-2#,2#-DIFLUOROCYTIDINE
AU2005328519B2 (en) * 2005-03-04 2012-03-01 Fresenius Kabi Oncology Limited Intermediate and process for preparing of beta- anomer enriched 21deoxy, 21 ,21-difluoro-D-ribofuranosyl nucleosides
WO2006095359A1 (en) * 2005-03-10 2006-09-14 Sms Pharmaceuticals Limited Synthesis of 2-deoxy-2, 2-di fluoro-d-ribo furanose-3, 5 di(4-methy/4-nitro-chloro)benzoate and its conversion to gemcitabine hydrochloride thereof
US7485716B2 (en) * 2005-05-02 2009-02-03 Pharmaessentia Corp. Stereoselective synthesis of β-nucleosides
CN100391966C (zh) * 2005-06-17 2008-06-04 华东师范大学 一种2’-脱氧-2’，2’-二氟-胞苷合成的方法
EP1940859A1 (en) 2005-10-28 2008-07-09 Arch Pharmalabs Limited An improved process for preparation of gemcitabine hydrochloride
KR101259637B1 (ko) * 2005-12-14 2013-04-30 주식회사종근당 1-(2´-데옥시-2´,2´-디플루오로-디-리보푸라노실)-4-아미노피리미딘-2-온또는 그의 염산염의 제조방법
US20090069354A1 (en) * 2007-09-12 2009-03-12 Protia, Llc Deuterium-enriched gemcitabine
JO2778B1 (en) 2007-10-16 2014-03-15 ايساي انك Certain vehicles, installations and methods
CN101883570B (zh) * 2007-11-06 2013-06-19 药华医药股份有限公司 β-核苷的新颖合成
IT1393062B1 (it) * 2008-10-23 2012-04-11 Prime Europ Therapeuticals Procedimento per la preparazione di gemcitabina cloridrato
US8609631B2 (en) 2009-04-06 2013-12-17 Eisai Inc. Compositions and methods for treating cancer
JO3197B1 (ar) * 2009-04-06 2018-03-08 Otsuka Pharma Co Ltd (مشتقات 2'-دايوكسي-ريبوفيورانوسيل) 1 , 3 , 4, 7- تترا هيدرو- (1, 3) داي آزيبين- 2 - أون لعلاج السرطان
JP5684787B2 (ja) * 2009-04-06 2015-03-18 大塚製薬株式会社 シチジンベースの抗新生物薬とシチジンデアミナーゼ阻害薬との組合せ、および癌の治療におけるその使用
UY32546A (es) * 2009-04-06 2010-10-29 Eisai Inc Composiciones y metodos para tratar cancer
CN101525361B (zh) * 2009-04-21 2010-11-17 济南圣鲁金药物技术开发有限公司 基于吉西他滨结构的前药及其合成方法及应用
DK2431376T4 (da) * 2009-05-15 2024-02-26 Delta Fly Pharma Inc Ny stabilt krystal af 1-(2'-cyano-2'-deoxy-ß-D-arabinofuranosyl)cytosinmonohydrochlorid
CN101628927B (zh) * 2009-08-07 2012-10-10 卡硼瑞（北京）科技有限公司 以1,3,5-三-O-苯甲酰基-α-D-呋喃核糖为原料立体选择性制备β-二氟胞苷盐酸盐的方法
CN102453064B (zh) * 2011-06-30 2014-07-09 江苏豪森药业股份有限公司 制备吉西他滨盐酸盐的方法
CN102659884B (zh) * 2012-04-23 2014-07-02 南京臣功制药股份有限公司 盐酸吉西他滨的提纯方法
CN103224541B (zh) * 2013-04-27 2015-07-01 江苏豪森药业股份有限公司 吉西他滨α-异构体转化回收工艺
CN104402945A (zh) * 2014-11-27 2015-03-11 苏州乔纳森新材料科技有限公司 一种3-脱氧-1,2-o-异丙叉-d-呋喃木糖的合成方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3817978A (en) * 1971-06-16 1974-06-18 Syntex Inc 4-fluoro nucleosides and sugar intermediates, and methods of preparing
JPS5924999B2 (ja) * 1978-06-10 1984-06-13 富山化学工業株式会社 新規な５−フルオロ−２′−デオキシ−β−ウリジン誘導体の製造法
US4526988A (en) * 1983-03-10 1985-07-02 Eli Lilly And Company Difluoro antivirals and intermediate therefor
DE3587500T2 (de) * 1984-12-04 1993-12-16 Lilly Co Eli Tumorbehandlung bei Säugetieren.
US5223608A (en) * 1987-08-28 1993-06-29 Eli Lilly And Company Process for and intermediates of 2',2'-difluoronucleosides
US4965374A (en) * 1987-08-28 1990-10-23 Eli Lilly And Company Process for and intermediates of 2',2'-difluoronucleosides
JPH0673086A (ja) * 1992-06-22 1994-03-15 Eli Lilly & Co 立体選択的な陰イオングリコシル化法
UA41261C2 (uk) * 1992-06-22 2001-09-17 Елі Ліллі Енд Компані Спосіб одержання збагачених бета-аномером нуклеозидів
AU4134793A (en) * 1992-06-22 1993-12-23 Eli Lilly And Company 2'-deoxy-2',2'-difluoro(2,6,8-substituted) purine nucleosides having anti-viral and anti-cancer activity and intermediates
CA2105112C (en) * 1992-09-01 2005-08-02 Thomas C. Britton A process for anomerizing nucleosides
US5637688A (en) * 1994-12-13 1997-06-10 Eli Lilly And Company Process for preparing 1-(2'-deoxy-2'-difluoro-d-ribofuranosyl)-4-aminopyrimidin-2-one hydrochloride

Also Published As

Publication number Publication date
NO972679D0 (no) 1997-06-11
PE49296A1 (es) 1996-11-21
GR3030265T3 (en) 1999-08-31
CZ179897A3 (en) 1997-09-17
DE69509624D1 (de) 1999-06-17
CZ290941B6 (cs) 2002-11-13
RU2154648C2 (ru) 2000-08-20
TW379226B (en) 2000-01-11
AU4110196A (en) 1996-07-03
DK0719788T3 (da) 1999-11-01
IL115852A (en) 1999-09-22
DE69509624T2 (de) 1999-10-07
EP0719788B1 (en) 1999-05-12
IL115852A0 (en) 1996-01-31
MY112488A (en) 2001-06-30
BR9509979A (pt) 1998-06-09
JPH10510806A (ja) 1998-10-20
MX9704322A (es) 1997-09-30
PL181732B1 (en) 2001-09-28
US5808048A (en) 1998-09-15
PL321046A1 (en) 1997-11-24
UA48152C2 (uk) 2002-08-15
ATE179986T1 (de) 1999-05-15
BG62738B1 (bg) 2000-06-30
BG101591A (en) 1998-03-31
CN1047177C (zh) 1999-12-08
NO306783B1 (no) 1999-12-20
CO4520286A1 (es) 1997-10-15
KR100424991B1 (ko) 2004-05-20
NZ296476A (en) 1998-12-23
SI0719788T1 (en) 1999-10-31
YU49314B (sh) 2005-06-10
HUT77929A (hu) 1998-11-30
ZA959320B (en) 1997-05-05
WO1996018637A1 (en) 1996-06-20
EP0719788A2 (en) 1996-07-03
EP0719788A3 (en) 1996-09-25
US5637688A (en) 1997-06-10
HU219021B (hu) 2001-01-29
NO972679L (no) 1997-06-11
AU689674B2 (en) 1998-04-02
ES2130542T3 (es) 1999-07-01
RO117327B1 (ro) 2002-01-30
AR001041A1 (es) 1997-09-24
CN1169728A (zh) 1998-01-07

Similar Documents

Publication Publication Date Title
YU70895A (sh) Postupak za pripremanje 1-(2'-deoksi-2',2'-difluoro-d-ribofuranosil)-4-(aminopirimidin-2-on)hidrohlorida
NO308660B1 (no) Nye 2,3-diketopiperazin-derivater eller deres salter, anvendelse derav og farmasøytisk preparat inneholdende slike
MX9504332A (es) Derivados de amino(tio)eter y procedimiento para su preparacion.
FR2715847B1 (fr) Composition contenant des acides nucléiques, préparation et utilisations.
FR2738835B1 (fr) Composition epaissie en milieu aqueux, procede d'epaississement d'un milieu aqueux et utilisations en cosmetique
DZ2036A1 (fr) N-(indole-2-carbonyl)-beta-alaninamides substituéset leurs dérivés, servant d'agents antidiabétiques.
DK204085A (da) Pyrazolderivater, deres fremstilling og farmaceutiske anvendelse
MY141641A (en) Compositions comprising viruses and methods for concentrating virus preparations
CA2321461A1 (en) Cross-linked high amylose starch having functional groups as a matrix for the slow release of pharmaceutical agents
DK0832104T3 (da) Dolastatinderivater, deres fremstilling og anvendelse
BR0016083A (pt) Solução aquosa de um amido modificado, meio cosmeticamente aceitável, e, método para tratamento de um substrato que contém queratina.
AU2770097A (en) Polymer powders redispersible in aqueous solution
ATE181921T1 (de) Chromatographische isolierung von nucleinsäuren
NO970610L (no) Sammensetning for selektiv frigjöring av en aktiv ingrediens
DE69632193D1 (de) Cyclooxygenaseinhibitor und salze von amidinderivaten, verfahren zu deren herstellung, deren verwendung als arzneiwirkstoffe sowie diese salze enthaltende arzneimittel
ATE259369T1 (de) Neue geranylgeranylderivate, verfahren zu deren herstellung und entsprechende pharmazeutische zusammensetzungen
TR199900770T2 (xx) Nazal poliplerin tedavisinde bir H+, K+-ATPase'�n kullan�lmas�.
SE9402880D0 (sv) New peptide derivatives
DK0465581T3 (da) Erythromycinderivater
DK0701554T3 (da) Benzisoselen-azolinderivater og -azinderivater, fremgangsmåde til fremstilling heraf og deres terapeutiske anvendelse
BG105204A (en) Salts of paroxetine
FR2654081B1 (fr) Distributeur d'objets de faible epaisseur et de forme rectangulaire, par exemple de tickets.
SE9400524D0 (sv) Energipreparat
NO174532C (no) 1-metyl-3,5,7-triaza-1-azoiatricyklodekanforbindelser, deres anvendelse ved kontroll av mikro-organismer i vandige system og ved inhibering av korrosjon
ES2153594T3 (es) Agente de recubrimiento termoendurecible y su utilizacion.